Anti-PARK7/DJ1 antibody [EP2816Y]
- BOND RX™ Validated
- RabMAb
- KO Validated
- Recombinant
- What is this?
5
(1 Review)
|
(9 Publications)
Rabbit Recombinant Monoclonal PARK7/DJ1 antibody. Suitable for IHC-P, WB, Flow Cyt (Intra) and reacts with Human, Rat, Mouse samples. Cited in 9 publications.
View Alternative Names
Parkinson disease protein 7, Maillard deglycase, Oncogene DJ1, Parkinsonism-associated deglycase, Protein DJ-1, Protein/nucleic acid deglycase DJ-1, DJ-1, PARK7
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-PARK7/DJ1 antibody [EP2816Y] (AB76241)
Flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized Jurkat (human T cell leukemia T lymphocyte from peripheral blood) cells labelling PARK7/DJ1 with ab76241 at 1/20 dilution (7.5 ug/mL) (Red) compared with a isotype control (Black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody).
Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/5000 dilution was used as the secondary antibody.
- ICC/IF
Collaborator
Immunocytochemistry/ Immunofluorescence - Anti-PARK7/DJ1 antibody [EP2816Y] (AB76241)
ab76241 was shown to react with PARK7 in wild-type HEK-293T cells in immunocytochemistry with loss of signal observed in PARK7 knockout cell line ab266338. Wild-type and knockout cells were mixed and pelleted at a 1 : 1 ratio on coverslips. The cells were fixed with 4% paraformaldehyde (15 min) then permeabilized with 0.1% Triton X-100 (10min) and then blocked with 1x PBS, 0.01% Triton X-100, 5% BSA, 5% NGS. The cells were then incubated with ab76241 at 1/100 dilution overnight at 4°C followed by a further incubation at room temperature for 1h with a goat anti-rabbit secondary antibody to (Alexa Fluor® 555) at 0.5 µg/ml. Acquisition of the green (wild-type), red (antibody staining) and far-red (knockout) channels was performed. Representative grayscale images of the red channel are shown. Wild-type and knockout cells are outlined with yellow and magenta dashed line, respectively. Schematic representation of the mosaic strategy used is shown on the bottom-right panel. Image was acquired with a Zeiss(LSM-880).
This data was provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PARK7/DJ1 antibody [EP2816Y] (AB76241)
Immunohistochemical analysis of paraffin-embedded Human cerebrum tissue labeling PARK7/DJ1 with ab76241 at 1/500 (0.494 ug/ml) dilution.
Positive staining on human cerebrum tissue. The section was incubated with ab76241 for 30 mins at room temperature.
The immunostaining was performed on a Leica Biosystems BOND® RX instrument
Counterstained with Hematoxylin.
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PARK7/DJ1 antibody [EP2816Y] (AB76241)
Immunohistochemical analysis of paraffin-embedded Mouse cerebrum tissue labeling PARK7/DJ1 with ab76241 at 1/500 (0.494 ug/ml) dilution.
Positive staining on mouse cerebrum tissue. The section was incubated with ab76241 for 30 mins at room temperature.
The immunostaining was performed on a Leica Biosystems BOND® RX instrument
Counterstained with Hematoxylin.
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PARK7/DJ1 antibody [EP2816Y] (AB76241)
Immunohistochemical analysis of paraffin-embedded Rat cerebrum tissue labeling PARK7/DJ1 with ab76241 at 1/500 (0.494 ug/ml) dilution.
Positive staining on rat cerebrum tissue. The section was incubated with ab76241 for 30 mins at room temperature.
The immunostaining was performed on a Leica Biosystems BOND® RX instrument
Counterstained with Hematoxylin.
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins
- WB
Collaborator
Western blot - Anti-PARK7/DJ1 antibody [EP2816Y] (AB76241)
ab76241 was shown to react with PARK7 in wild-type HEK-293T cells in Western blot with loss of signal observed in PARK7 knockout cell line ab266338. Wild-type HEK-293T and PARK7 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hr before incubation with ab76241 overnight at 4 °C at a 1/2000 dilution. Blots were incubated with secondary antibodies at 0.2 µg/mL before imaging.
This data was provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.
All lanes:
Western blot - Anti-PARK7/DJ1 antibody [EP2816Y] (ab76241) at 1/2000 dilution
Lane 1:
Wild-type HEK-293T lysate at 30 µg
Lane 2:
PARK7 knock-out HEK-293T lysate at 30 µg
Lane 2:
Western blot - Anti-PARK7/DJ1 antibody [EP2816Y] (ab76241) at 30 µg
false
- WB
Lab
Western blot - Anti-PARK7/DJ1 antibody [EP2816Y] (AB76241)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Exposure time :
Lane 1 : 10 seconds;
Lane 2 : 5 seconds;
Lane 3 : 3 seconds.
All lanes:
Western blot - Anti-PARK7/DJ1 antibody [EP2816Y] (ab76241) at 1/2000 dilution
Lane 1:
Jurkat (Human T cell leukemia T lymphocyte) whole cell lysate at 15 µg
Lane 2:
Mouse brain lysate at 15 µg
Lane 3:
Rat brain lysate at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/200000 dilution
Predicted band size: 20 kDa
Observed band size: 24 kDa
false
Related conjugates and formulations (1)
-
Anti-PARK7/DJ1 antibody [EP2816Y] - BSA and Azide free
Reactivity data
Product details
Production method for this product has been changed from hybridoma to recombinant on 15th August 2024
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (9)
Recent publications for all applications. Explore the full list and refine your search
Redox biology 60:102631 PubMed36791646
2023
Applications
Unspecified application
Species
Unspecified reactive species
Neurochemistry international 139:104791 PubMed32650030
2020
Applications
Unspecified application
Species
Unspecified reactive species
Aging cell 19:e13140 PubMed32291905
2020
Applications
Unspecified application
Species
Unspecified reactive species
Nature methods 15:909-912 PubMed30377371
2018
Applications
Unspecified application
Species
Unspecified reactive species
Clinical genetics 92:18-25 PubMed27460976
2016
Applications
Unspecified application
Species
Unspecified reactive species
Journal of neurochemistry 130:839-53 PubMed24832775
2014
Applications
Unspecified application
Species
Unspecified reactive species
Journal of proteome research 13:2339-51 PubMed24646099
2014
Applications
Unspecified application
Species
Unspecified reactive species
Analytical biochemistry 443:197-204 PubMed24055619
2013
Applications
Unspecified application
Species
Unspecified reactive species
Proteomics 9:5509-24 PubMed19834913
2009
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com